REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WELLS FARGO & COMPANY/MN | 72,007 | $1,822,497 | 0.00% |
GROUP ONE TRADING, L.P. | 8,777 | $222,146 | 0.00% |
Legal & General Group Plc | 77,918 | $1,972,104 | 0.00% |
JANUS HENDERSON GROUP PLC | 38,575 | $975,762 | 0.00% |
NATIXIS | 6,455 | $163,376 | 0.00% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 8,530 | $215,894 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 33,454 | $847 | 0.00% |
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 23,681 | $599,366 | 0.00% |
Janney Montgomery Scott LLC | 16,010 | $405 | 0.00% |
DEUTSCHE BANK AG\ | 39,842 | $1,008,401 | 0.00% |
CITIGROUP INC | 38,708 | $979,699 | 0.00% |
MERCER GLOBAL ADVISORS INC /ADV | 9,161 | $232 | 0.00% |
UBS ASSET MANAGEMENT AMERICAS LLC | 90,914 | $2,928,340 | 0.00% |
Parallax Volatility Advisers, L.P. | 10,085 | $255,251 | 0.00% |
UBS Group AG | 130,025 | $3,290,932 | 0.00% |
KEYBANK NATIONAL ASSOCIATION/OH | 13,021 | $329,562 | 0.00% |
WOLVERINE TRADING, LLC | 27,800 | $686,660 | 0.00% |
WOLVERINE TRADING, LLC | 33,100 | $817,570 | 0.00% |
WOLVERINE TRADING, LLC | 19,346 | $477,846 | 0.00% |
Point72 Asset Management, L.P. | 11,300 | $286,003 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.